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Permeabilisation of PC12 cells with digitonin allowed a direct study of the intracellular action of botulinurn nemotoxin A, one of a group of dichain 
proteins produced by CIostridium botulinurn that causes the fatal neuroparalytic ondition, botulism. Release of PHlnoradrenaiine from these per- 
meabilised cells could be evoked by Ca2* and this was inhibited specifically by the neurotoxin in a dose-dependent manner (half-m~imal dose 
~2 nM under the conditions used). Inclusion of the reducing agent di~ioth~itol (up to 10 mM) had no effect on the level of in~bition, Moreover, 
eiectrophoretic analysis howed that this treatment of the toxin in the native state caused negligible reduction of inter-chain disulphide bonds. Toxin- 
induced blockade of neurotransmitter release was incomplete and could not be overcome by increased Ca*+ concentration (100 PM), The observed 
toxin-insensitivity of the release from intact PC12 cells must result from inefficient oxin uptake, relative to that in peripheral cholinergic neurones. 
Refolded light chain alone inhibited exocytosis to the same degree and with similar potency to that of the intact neurotoxin, an effect not altered 
by the heavy chain. This inhibitory activity of the light chain in PC12 eelIs accords with observations made in permeabilised chromaflin cells [(t989) 
J. Biol. Chem. 264, 103~IO3~; (I939) FEBS Lett. 255, 391~3941 but contrasts with invertebrate neurones, where intraceltular injection of the 
same preparations ofboth chains were necessary for inhibition ofquantai release of acetykholine [(19gg) Proc. Natl. Acad. Sci. USA 85,40%+%94]. 
These collective findings may signify an interesting difference in the release process in such diverse systems or denote a dissimiIarity in the transport 
or processing of the toxin when applied into intact neurones or cells permeabitised by detergent or streptdysin. 
Botulinurn neurotoxin; Noradrenaline release; Permeabilisation; Exocytosis; (PC12 cells) 
1. INTRODUCTION 
Botulinurn neurotoxin (BoNT) type A is one of a 
family of closely-related proteins (Mr -I5~~~ pro- 
duced by different strains of ~~~~t~~d~~~ ~~~~~j~~~ 
(reviewed in [l]). Its unique toxicity results from a 
remarkably potent blockade of acetylcholine release 
from peripheral nerve endings [2]. Although BoNT bin- 
ding is specific to cholinergic nerves [3], a prerequisite 
for its internalization [4] and action [S], secretion in 
other cells can be blocked when toxin uptake is by- 
passed [5-71. BoNT is synthesised as a single chain, but 
only becomes fully toxic following proteolytic process- 
ing to a disulphide linked dichain form, composed of 
a heavy (&& -100000; I-K!) and a light (&& -5OooO; 
LC) chain f 1,2]. The individual chains can be separated 
and, after refolding, each is relatively non-toxic in mice 
and ineffective on neuromuscular transmission [8]. 
Moreover, when injected separately into Aplyr&r 
neurons no alteration in transmitter release ensues; 
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however, nerve-evoked release of aceetylcholine is in- 
hibited when both chains are administered [S]. 
Because intraneuronal action of the chains cannot be 
tested directly in vertebrate motor nerves, PC12 cells 
were used here to ascertain if both polypeptides are 
ge~e~~~~~ required intracellularly for the blockade of 
Ca2+-evoked neurotransmitter release. This is par- 
ticularly pertinent because LC of BoNT [9,10] or 
tetanus toxin [ 11,121 were shown recently to block exo- 
cytosis from chromaffin cells. PC12 cells offer the ad- 
vantage of being a relatively homogeneous population 
of neurone-like cells which are convenient for measure- 
ment of secretion, before and after differentiation [ 131. 
Moreover, cell permeabilisation with digitonin [9,1 l] or 
pore-forming toxins [10,12] allows constituents in the 
intracellular milieu to be altered and, also, affords ac- 
cess of the toxin to its ph~ma~ologi~al target, whilst 
enabling quantitation of exocytosis. Another facet ad- 
dressed herein is whether treatment of BoNT A with 
DTT increases its potency in blocking exocytosis as 
reported for StreptoIysin-permeabilised [ 141 but not 
digitonin-treated chromaffin cells. 
2. EXPERIMENTAL 
2.1. Materials 
Homogeneous BoNT A was purified from Ctostri&m bott&um 
&rain NCTC 7272) to a specific toxicity of z x IO8 mouse LDxt 
unitslmg and its two chains were isolated as described previously, 
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with their purity being ascertained by SDS polyacrylamide gel elec- 
trophoresis [8]. The individual chains, obtained in buffer containing 
DTT and urea, were renatured by repeated ialysis, with agitation at 
4°C for a minimum of 4 h, into Kgep (139 mM K+ glutamate/20 mM 
Pipes/5 mM EGTA/l mM Mg*+-ATP/S mM glucose/O.5 mM 
ascorbic acid, pH 6.6). The preparations were stored at 4’C; any in- 
soluble material was removed by centrifugation and protein concen- 
trations of the chains were determined [15]. Antibodies against BoNT 
A were raised in rabbits as detailed elsewhere [16]; 1 ml of the an- 
tiserum neutralised 10’ mouse LDso units of BoNT A. 
2.2. Permeabilisation of PC12 cells and measurement of 
noradrenaline release 
PC12 cells were grown on 100 mm dishes in Dulbecco’s modifica- 
tion of Eagle’s medium supplemented with 10% (v/v) horse serum, 
5% (v/v) foetal calf serum, 3 mM glutamine and including penicillin 
(100 W/ml) and streptomycin (lOO~g/ml) (all from Flow 
Laboratories Ltd., Rickmansworth, England). Cells were plated at 2 
x lo3 cells/mm2 on polylysine-coated, 24-well multi-wells (Falcon 
Labware, Marathon Laboratory Supplies, London) 1 or 2 days prior 
to use. Intact cells were incubated in the absence or presence of 
BoNT, washed, loaded with [‘H]noradrenaline and the levels of 
Ca*+-dependent resting and depolarisation-induced release of 
transmitter from replicate wells was quantified as detailed in fig. 1. 
For permeabilisation experiments, cells were loaded with 
[‘Hlnoradrenaline and washed, as detailed for the intact cells (fig.1 
legend). Optimal permeabilisation conditions were: 7.5 pM digitonin 
(Fluka Chemicals Ltd., Glossop, England) in 250~1 of Kgep for 
5 min at room temperature [9]. Following removal of the medium, 
the quantities of [‘Hlnoradrenaline and lactate dehydrogenase (a 
cytoplasmic marker) released on permeabilisation were determined. 
Cells were then treated with the desired concentration of BoNT A in 
250~1 of Kgep containing 1 mg/ml albumin and 1 mM NAD+ for 
15 min at 30°C. Neurotransmitter release was stimulated for 5 min at 
room temperature, with 1OpM free Ca*+ calculated by a computer 
programme [17] to require the addition of 4.43 mM CaCl2 to the 
Kgep buffer with albumin. Ca*+-independent release was measured 
similarly but with the omission of Ca*+ from the buffer. All samples 
were counted at an efficiency of 35% in scintillation cocktail (3: 1 
xylene/Triton, 0.3% PPO). The radioactive content of the cells was 
determined, likewise, after solubilization in 250 pl of 1 Vo (v/v) Triton 
X-108 for 5 min. 
2.3. SDS polyacrylamide gel electrophoresis 
Gels of 10% acrylamide were cast and samples prepared as describ- 
ed previously [8]. 
3. RESULTS 
Release of [3H]noradrenaline by intact PC12 cells in- 
duced by depolarization with high concentrations of K+ 
was highly dependent upon Ca2+ in the medium (Fig. 
1A). Exposure to BoNT A failed to inhibit either the 
resting or the K+-evoked release of noradrenaline from 
the cells (Fig. lA), presumably due to a lack of toxin 
uptake because of the known absence of BoNT A bin- 
ding sites on PC12 cells (A.C. Ashton and J.O. Dolly, 
unpublished data). To overcome this, the cells were 
treated with digitonin under conditions that gave 
permeabilisation of the plasma membrane without 
causing appreciable leakage of vesicular 
[3H]noradrenaline. The ability to release noradrenaline 
in response to Ca2+ (10 PM free concentration) was re- 
tained after this treatment (fig.lB). BoNT A did not 
lower the Ca2+-independent efflux; in contrast, it great- 
ly reduced the Ca2+-dependent transmitter elease from 
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Fig. 1. The effect of BoNT A on neurotransmitter release from non- 
permeabilised and permeabilised PC12 cells. Intact cells (A) were 
incubated at 37°C overnight in 250~1 of medium with or without 
200 nM BoNT A. This was replaced with 250~1 of medium 
containing 0.4 ,&i [7,8-‘Hlnoradrenaline (15 Ci/mmol, Amersham 
International, Bucks) for 1.5 h at 37°C. After three washes with 
medium containing 25 mM Hepes, pH 7.4, intact cells were 
incubated at room temperature for 5 min without any additions, with 
45 mM KC1 or with 45 mM KC1 and 10 mM EGTA. Permeabilised 
(see section 2) cells (B) were treated for 15 min at 30°C with KGEP 
(+ albumin/NAD’) with or without 200 nM BoNT A, followed by 
a 5 min incubation with KGEP (+ albumin) with or without 10 PM 
free Ca*+. The amounts of radioactivity released were quantified by 
scintillation counting and expressed as % of the cellular content (in 
the case of permeabilised cells after digitonin and toxin treatment). 
Points (k SD) presented are from 4 independent wells for each 
condition and are representative of at least 10 experiments. 
the permeabilised cells. Notably, toxin treatment failed 
to completely abolish the efflux (fig.lB; see below). 
The specificity of the blockade produced by BoNT was 
ascertained by loss of the effects seen when antiserum 
against the toxin was included (fig.2). Stimulation with 
high concentrations of free Ca2+ (up to IOOpM) pro- 
duced a further (-20%) increase in release indicating 
that the standard concentration used (10 PM) was close 
to optimal; however, the raised level of Ca2+ did not 
overcome the BoNT-induced blockade (fig.2). BoNT A 
intoxication was temperature-dependent with much 
reduced effect on release being evident at room 
temperature (not shown). 
‘““1 
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Fig.2. The specific reduction of Ca*+- evoked noradrenaline release is 
not reversed by increasing the Ca2+ concentration. Cells 
permeabilised as in fig.lB were treated with buffer, BoNT A, anti- 
BoNT antiserum or BoNT A plus anti-BoNT antiserum as illustrated. 
Release was evoked by 10 or 100 pM free Ca*‘; Ca’+-independent 
release was subtracted and the Ca*+-dependent release expressed as 
a Vo of the control value. The results presented (+ SD) are the means 
of data from 16 wells with and 16 without Ca*+. 
Volume 261, number 2 FEBS LETTERS February 1990 
BoNT blockade of noradrenaline release was dose- 
dependent (fig.3) with a half-maximal effect at -2 nM. 
Higher concentrations of BoNT (up to 1 PM) did not 
lead to further reduction in the level of release (not 
shown); therefore, there exists a BoNT A-insensitive 
fraction of Ca*+-evoked transmitter release. Adding 
DTT (10 mM) did not alter the evoked release from the 
cells and likewise caused no significant increase in the 
effectiveness of a sub-optimal concentration of BoNT 
A in blocking secretion (fig.4A). 
The individual chains of BoNT A were isolated as 
described previously and shown to be homogeneous by 
SDS polyacrylamide gel electrophoresis (see [8]); 
following refolding of the separate chains, each 
preparation was found to have low toxicity when in- 
jected into mice (> 105-fold lower than that of intact 
BoNT). Moreover, neither chain (30 nM) produced 
any blockade of neurotransmission in mouse 
hemidiaphragm over 6 h [8]. When added to the 
permeabilised cells LC alone yielded a reduction in 
noradrenaline release comparable to that of the native 
toxin (figs 3 and 4). HC (100 PM) had no measurable 
effect on transmitter elease; furthermore, inclusion of 
100 nM HC with 2 nM LC did not increase the in- 
hibitory activity of this sub-optimal concentration of 
LC alone (fig.4B). 
The ability of varying concentrations of DTT were 
tested electrophoretically for their ability to reduce the 
toxin’s interchain disulphide bonds under non- 
denaturing conditions. Following a brief incubation 
with DTT in the KGEP buffer, excess iodoacetamide 
was added to the mixture to prevent further reduction 
of disulphides exposed on denaturation of the toxin 
with SDS. The protein was then subjected to SDS 
polyacrylamide gel electrophoresis (fig.5). There was 
no detectable reduction of the disulphide bridge bet- 
ween the two polypeptide chains of the native toxin 
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Fig.3. Dose dependence of the inhibition by BoNT A or its LC of 
Ca2+-dependent release of [‘Hlnoradrenaline from permeabilised 
PC12 cells. After loading, washing and treatment with digitonin, the 
cells were incubated with varying concentrations of BoNT (a) or 
light chain (0), prior to measurement of release as detailed in 
section 2 and fig.1. Release is expressed as a percentage of the 
control, in the absence of toxin preparation. Points (& SD) are for 
8 wells with and 8 without Ca2+. 29 kDa, bovine erythrocyte carbonic anhydrase. 
Fig.5. SDS polyacrylamide gel electrophoresis of BoNT A treated 
with DTT or iodoacetamide. Samples of BoNT A (5 pg) were treated 
with 1 mM, with 10 mM or without DTT as shown. After 10 min at 
room temperature, iodoacetamide (5 x the DTT concentration) was 
then added to prevent further reduction. Lanes are 1, 10 mM DTT; 
2, 10 mM DTT + iodoacetamide; 3, 1 mM DTT; 4, 1 mM DTT + 
iodoacetamide; 5, BoNT A only; 6, BoNT A boiled in 
2-mercaptoethanol. Molecular mass standards were: 116 kDa, E. co/i 
,&galactosidase; 66 kDa, bovine albumin; 45 kDa, egg albumin; 
36 kDa, rabbit muscle glyceraldehyde-3-phosphate dehydrogenase; 
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Fig.4. Reduction of noradrenaline release from permeabilised PC12 
cells by BoNT or its chains. Cells were permeabilised as before and 
then treated as illustrated in A and B. Release was evoked as 
described earlier with or without 1OpM free Ca2+ and 
Ca2+-dependent release xpressed as a % of the control. Data ( f SD) 
are the mean of 16 with and 16 without Ca2+. 
with 1 mM DTT when iodoacetamide was included 
after the initial reduction; similar treatment with 
10 mM DTT caused cleavage of a small proportion of 
the molecules into their constituent chains (fig.5). 
When iodoacetamide was omitted some separation of 
the chains was seen with 1 mM DTT and this was more 
pronounced with the higher concentration used, in- 
dicating that unfolding of the toxin with SDS is needed 
to allow reduction to occur. 
4. DISCUSSION 
The ability of digitonin-permeabilised PC12 cells to 
release transmitter in a Ca*+-dependent manner was ex- 
ploited to investigate the intracellular inhibitory action 
of BoNT and’its chains. Native BoNT produced an ex- 
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tensive inhibition (60-70%) of Ca2+-evoked release of 
noradrenaline from the permeabilised cells, consistent 
with the intracellular inhibition of exocytosis in 
chromaffin cells revealed either by measuring release 
directly [9,14] or membrane capacitance changes [6]. 
The half-maximal concentration of the toxin (-2 nM) 
in PC12 cells approximates to the values reported for 
chromaffin cells [9,14] and to the concentration (5 nM) 
effective intracellularly over l-2 h in Aplysia neurones 
[5]. Although a lower toxin concentration has been 
found to be active following bath application of BoNT 
to mammalian motor nerves [8], any apparent 
discrepancy is likely to arise from the shorter time 
(15 min) of exposure to BoNT (enforced by the ex- 
perimental system) rather than from a difference in the 
toxin’s potency on different transmitters because a 
similar blockade of evoked quanta1 release has been 
observed in cholinergic and non-cholinergic neurones 
of Aplysia [5]. Treatment of the toxin with DTT did 
not improve the potency, in agreement with results ob- 
tained with chromaffin cells permeabilised under the 
same conditions [9]. As the DTT does not break the in- 
terchain disulphide bridge of BoNT A (fig.5), the ap- 
parent enhancement of intoxication seen in streptolysin 
0-permeabilised chromaffin cells [14] may arise from 
reduction of intradisulphide bonds; although this effect 
may be a feature of the latter cell system it is curious 
that reduction enhanced type B neurotoxin-mediated 
inhibition in digitonin-treated chromaffin cells [9]. 
Notably, BoNT-induced inactivation of the release 
process was achieved in Ca’+-free medium containing 
EGTA; thus, the reported involvement of Ca2+ [18] 
must relate to another step of the intoxication (e.g. tox- 
in transport to the cytosol). Moreover, the increased 
Ca2+ concentration failed to reverse the inhibition in 
the toxin-treated, permeabilised cells; the reversibility 
seen at the mammalian neuromuscular junctions (cf. 
[2]), could indicate a difference between the two 
systems or, more probably, incomplete inactivation in 
the latter preparation. Whereas nerve-evoked release at 
motor nerve terminals is virtually abolished by BoNT A 
treatment [ 1,2], inhibition in the cells was incomplete, 
even at the highest toxin concentration tested (1 /cM). 
Nevertheless, this anomaly may be due to the ex- 
perimental conditions used (e.g. restricted time of ex- 
posure to toxin; loss of cellular constituents on 
permeabilisation; incomplete permeabilisation of a 
proportion of the cells allowing Ca2+ entry but not af- 
fording access to the much larger toxin molecule) or 
could reflect two separate pools of neurotransmitter. 
Isolated, re-natured LC inhibited neurotransmitter 
release from the digitonin-permeabilised PC12 cells in 
a dose-dependent fashion and with similar efficacy to 
the intact toxin (fig.3); and it approximates to LC- 
treated chromaffin cells [9,10]. Inclusion of excess 
isolated, renatured HC with LC failed to increase this 
level of inhibition. Interestingly, and by contrast, 
326 
isolated LC of tetanus toxin can inhibit neurotransmit- 
ter release from either permeabilised chromaffin cells 
[ 191 or when micro-injected into Apfysia neurones [20]. 
Thus, further experiments with mammalian neurones 
are needed to establish if these differences mirror 
evolutionary changes in the mechanism of 
Ca2+-dependent secretion, or if the method of 
noradrenaline release by endocrine-derived cells is 
distinct from that by neurones; alternatively, these fin- 
dings might be explained by a requirement of the 
transport of LC when injected into Aplysia neurones. 
At least variations in the isolation or refolding of the 
toxin’s chains have been excluded because identical 
results were obtained in the PC12 cells and Aplysia 
neurones with the same preparations of LC and HC; as 
well as samples kindly provided by Dr B.R. Dasgupta. 
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